Treatable neurological disorders misdiagnosed as Creutzfeldt-Jakob disease
- PMID: 21674591
- PMCID: PMC3170496
- DOI: 10.1002/ana.22454
Treatable neurological disorders misdiagnosed as Creutzfeldt-Jakob disease
Abstract
Objective: Heightened awareness of Creutzfeldt-Jakob disease (CJD) among physicians and the lay public has led to its frequent consideration in the differential diagnosis of patients with rapidly progressive dementia (RPD). Our goal was to determine which treatable disorders are most commonly mistaken for CJD.
Methods: We performed a retrospective clinical and neuropathological review of prion-negative brain autopsy cases referred to the US National Prion Disease Pathology Surveillance Center at Case Western Reserve University from January 2006 through December 2009.
Results: Of 1,106 brain autopsies, 352 (32%) were negative for prion disease, 304 of which had adequate tissue for histopathological analysis. Alzheimer disease (n = 154) and vascular dementia (n = 36) were the 2 most frequent diagnoses. Seventy-one patients had potentially treatable diseases. Clinical findings included dementia (42 cases), pyramidal (n = 20), cerebellar (n = 14), or extrapyramidal (n = 12) signs, myoclonus (n = 12), visual disturbance (n = 9), and akinetic mutism (n = 5); a typical electroencephalogram occurred only once. Neuropathological diagnoses included immune-mediated disorders (n = 26), neoplasia (n = 25, most often lymphoma), infections (n = 14), and metabolic disorders (n = 6).
Interpretation: In patients with RPD, treatable disorders should be considered and excluded before diagnosing CJD. Misdiagnosed patients often did not fulfill World Health Organization criteria. RPD with positive 14-3-3 cerebrospinal fluid protein should not be regarded as sufficient for the diagnosis of CJD. Adherence to revised criteria for CJD, which include distinctive magnetic resonance imaging features of prion disease, is likely to improve diagnostic accuracy.
Copyright © 2011 American Neurological Association.
Figures
Comment in
-
Thorough work-up and new diagnostic criteria needed for CJD.Nat Rev Neurol. 2011 Sep 5;7(9):479-80. doi: 10.1038/nrneurol.2011.118. Nat Rev Neurol. 2011. PMID: 21892213 Free PMC article.
Similar articles
-
[Eleven years of autopsy on account of Creutzfeldt-Jakob disease in the Netherlands].Ned Tijdschr Geneeskd. 2009;153:A172. Ned Tijdschr Geneeskd. 2009. PMID: 19785859 Dutch.
-
Rapidly progressive dementia due to intravascular lymphoma: A prion disease reference center experience.Eur J Neurol. 2024 Jan;31(1):e16068. doi: 10.1111/ene.16068. Epub 2023 Sep 22. Eur J Neurol. 2024. PMID: 37738529 Free PMC article.
-
[Psychiatric manifestations of a new variant of Creutzfeldt-Jakob disease. Apropos of a case].Encephale. 2001 Mar-Apr;27(2):194-7. Encephale. 2001. PMID: 11407273 French.
-
The evaluation of rapidly progressive dementia.Neurologist. 2011 Mar;17(2):67-74. doi: 10.1097/NRL.0b013e31820ba5e3. Neurologist. 2011. PMID: 21364356 Free PMC article. Review.
-
[Review of Creutzfeldt-Jakob disease and other prion diseases].Rev Neurol. 2000 Dec 16-31;31(12):1171-9. Rev Neurol. 2000. PMID: 11205554 Review. Spanish.
Cited by
-
Clinical, neuropathological, and molecular characteristics of rapidly progressive dementia with Lewy bodies: a distinct clinicopathological entity?Alzheimers Res Ther. 2024 Sep 10;16(1):201. doi: 10.1186/s13195-024-01565-x. Alzheimers Res Ther. 2024. PMID: 39256877 Free PMC article.
-
LGI1-antibody encephalitis: how to approach this highly treatable dementia mimic in memory and mental health services.Br J Psychiatry. 2024 Jun;224(6):252-257. doi: 10.1192/bjp.2024.72. Br J Psychiatry. 2024. PMID: 38699852 Free PMC article. Review.
-
IgLON5 autoimmunity in a patient with Creutzfeldt-Jakob disease: case report and review of literature.Front Neurol. 2024 Mar 20;15:1367361. doi: 10.3389/fneur.2024.1367361. eCollection 2024. Front Neurol. 2024. PMID: 38572492 Free PMC article.
-
[Clinical characteristics and diagnostics of human spongiform encephalopathies: an update].Nervenarzt. 2024 Apr;95(4):376-384. doi: 10.1007/s00115-024-01644-2. Epub 2024 Mar 19. Nervenarzt. 2024. PMID: 38503894 German.
-
Creutzfeldt-Jakob disease and other prion diseases.Nat Rev Dis Primers. 2024 Feb 29;10(1):14. doi: 10.1038/s41572-024-00497-y. Nat Rev Dis Primers. 2024. PMID: 38424082 Review.
References
-
- Geschwind MD, Martindale J, Miller D, et al. Challenging the clinical utility of the 14–3-3 protein for the diagnosis of sporadic Creutzfeldt-Jakob disease. Arch Neurol. 2003;60:813–816. - PubMed
-
- Satoh J, Kurohara K, Yukitake M, Kuroda Y. The 14–3-3 protein detectable in the cerebrospinal fluid of patients with prion-unrelated neurological diseases is expressed constitutively in neurons and glial cells in culture. Eur Neurol. 1999;41:216–225. - PubMed
-
- Poser S, Mollenhauer B, Kraubeta A, et al. How to improve the clinical diagnosis of Creutzfeldt-Jakob disease. Brain. 1999;122 ( Pt 12):2345–2351. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
